UNESCO Code: 320908 / 320999
Keywords:
Pharmaceutical care, nanomedicine, controlled release, pharmaceutical development, biopharmaceutics and pharmacokinetics.
Relevant characteristics of the research group (description of the group's activity):
The Pharmaceutical Care and Drug Development research group focuses, on the one hand, on the care approach to Pharmacy, conducting research on the impact of pharmaceutical intervention in the pharmacotherapeutic monitoring of patients, health education, medication reconciliation, deprescription, etc., in order to achieve results that improve the patient's quality of life. In this sense, the group directs and coordinates a Master's Degree in Pharmaceutical Care-Healthcare Pharmacy, which includes the direction of Master's End of Degree Project. Several Doctoral Theses related to pharmaceutical care are also being developed under the direction of the group's researchers.
On the other hand, the group's activity also includes research in the pharmaceutical development of drugs, as well as the study of their biopharmaceutical and pharmacokinetic behaviour, which allows to know how the drug is released from the designed dosage form and the kinetics of the processes involved in the transit of the drug through the body, such as absorption, distribution, metabolisation and excretion of the drug, whose knowledge allows a better adjustment of the dose and the dosage regimen of the drug, as well as to study the bioequivalence between drugs.
The group also researches in Nanomedicine, with the development of modified release systems such as microspheres, liposomes and nanoparticles that allow the drug to be delivered to a preferential area of the body and achieve a prolonged release of the drug, reducing the number of doses to be administered and the side effects of the drug.
Contact: [email protected]